ReviewCritical care (London, England)2026
Prevention of arterial catheter-related bloodstream infections: current evidence and future directions.
Review in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter to the editor - prevention of arterial catheter-related bloodstream infections: current evidence and future directions.Critical care (London, England) · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arterial catheters (ACs) are essential devices widely used for hemodynamic monitoring and blood sampling. Whilst their infectious risk is well-known, the surveillance and identification of arterial catheter-related bloodstream infections (AC-CRBSI) remains underappreciated, and guidelines recommending best practices to prevent infection are few and inconsistent. Most evidence for AC infection prevention is inferred from studies focused on central venous catheter infection prevention. Few studies have directly explored optimal infection prevention strategies for ACs. For AC-CRBSI prevention, several strategies are valuable during insertion and maintenance of the catheter: minimisation of catheter-days by appropriate catheter stewardship, procedural training of providers, standardisation of insertion packs to promote adherence to an insertion bundle, cutaneous antisepsis with an alcohol-based 2% chlorhexidine solution during insertion and maintenance, chlorhexidine impregnated dressings, change of dressing every 7 days unless visibly disrupted or soiled, hand hygiene, disinfection of the access port and change of administration sets every 7 days. Other interventions to prevent AC-CRBSI are more controversial and necessitate further research such as the choice of the insertion site (femoral vs. radial), the type of sterile barrier precautions and their cost effectiveness, the infectious risk related to ultrasound guidance, the optimal catheter securement device, the utility of needleless connectors and closed loop blood sampling systems and the effectiveness of scheduled catheter changes. Arterial catheters demonstrate an ongoing risk of contamination throughout their lifespan, from insertion to removal. A comprehensive prevention strategy should address the entire arterial catheter lifecycle and is most effective when implemented as a bundled approach. This review summarises current knowledge on AC-CRBSI prevention during the entire lifecycle of the catheter and identifies priorities for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.